In a human organoid-based mechanistic investigation, researchers revealed how an immunosuppressive drug, antithymocyte ...
The story of Q32 Bio, a company that develops therapeutics for inflammatory and autoimmune diseases, started two decades ago. That's when V. Michael Holers, MD, a University of Colorado School of ...
Leveraging human organoid-based mechanistic investigation, researchers reveal how an immunosuppressive drug, antithymocyte ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results